Coverage with Evidence Development
Magnetic Resonance Angiography and Magnetic Resonance Imaging
Added approved study
http://www.cms.gov/Medicare/ Coverage/Coverage-with- Evidence-Development/MRA_MRI. html
Added approved study
http://www.cms.gov/Medicare/
Magnetic Resonance Angiography and Magnetic Resonance Imaging
On February 8, 2011, the FDA granted approval of the first pacemaker designed for use in the MR environment for certain MRI exams. On February 24, 2011, CMS issued a NCD that provided coverage of MRI for beneficiaries with implanted pacemakers (PMs) or implantable cardiac defibrillators through Coverage with Evidence Development (CED)/Coverage with Study Participation (CSP) in approved clinical studies of MRI. The NCD was updated in July 2011 to remove the contraindication for Medicare coverage of MRI in beneficiaries with implanted PMs when the PMs are used according to the FDA-approved labeling for use in an MRI environment. Other contraindications that may be present in any given beneficiary continue to apply in patients with PMs.
Decision memo
Approved Studies
Study Title: Safety of MRI for Patients with Non-MRI Conditional Pacemakers and ICD Non-MRI Conditional Pacemakers and ICDSponsor: Lancaster General Hospital
ClinicalTrials.gov Number: NCT02318550
CMS Approval Date: 03/17/2015
Study Title: Confirmatory Clinical Trial of the Evera MRI System for Conditionally-safe MRI Access
Sponsor: Medtronic
ClinicalTrials.gov Number: NCT02117414
Investigational Device Exemption (IDE) Number: G140039
CMS Approval Date: 07/10/2014
Related Links
- Page last Modified: 03/30/2015 9:31 AM
No hay comentarios:
Publicar un comentario